Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


R2: Finding the Needle in Radiology's Haystack

Executive Summary

Over the past decade or so, the means of producing diagnostic images have improved greatly, but the technology for reading them has failed to keep pace. Radiologists read new computerized images with hand-held magnifying glasses, calipers and rulers, the same tools used for years. R2 Technology, by providing radiologists with better means of reading images through computer-aided detection software, is looking to carve out a niche in the diagnostic imaging market, where few small companies have ventured successfully. R2 is the first-to-market with FDA-approved CAD technology for breast cancer screening, and plans to develop this as a platform technology for other cancers, betting that its first-mover advantage helps establish the industry standard.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts